National Research Corporation
NRC
$18.10
$0.100.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.38% | -2.81% | -4.99% | -2.88% | -5.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.38% | -2.81% | -4.99% | -2.88% | -5.60% |
| Cost of Revenue | -18.95% | -3.34% | -5.77% | 4.04% | 4.59% |
| Gross Profit | 8.24% | -2.48% | -4.49% | -6.82% | -12.00% |
| SG&A Expenses | 11.68% | 58.04% | -7.95% | 3.28% | -6.69% |
| Depreciation & Amortization | 41.98% | 15.14% | 6.57% | 6.01% | -0.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.48% | 24.06% | -6.02% | 3.83% | -0.45% |
| Operating Income | -3.03% | -82.09% | -1.87% | -17.94% | -20.05% |
| Income Before Tax | -14.02% | -93.02% | -5.75% | -22.61% | -27.32% |
| Income Tax Expenses | 33.77% | -68.03% | 5.50% | -11.30% | -25.66% |
| Earnings from Continuing Operations | -27.53% | -101.72% | -9.00% | -25.94% | -27.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.53% | -101.72% | -9.00% | -25.94% | -27.78% |
| EBIT | -3.03% | -82.09% | -1.87% | -17.94% | -20.05% |
| EBITDA | 4.27% | -67.91% | -0.68% | -15.34% | -17.42% |
| EPS Basic | -24.73% | -103.25% | -5.44% | -22.49% | -25.20% |
| Normalized Basic EPS | -7.80% | -92.66% | -2.10% | -18.85% | -24.95% |
| EPS Diluted | -24.94% | -103.87% | -6.16% | -22.15% | -25.06% |
| Normalized Diluted EPS | -7.71% | -92.64% | -1.68% | -18.53% | -24.62% |
| Average Basic Shares Outstanding | -6.71% | -5.08% | -3.75% | -4.43% | -3.42% |
| Average Diluted Shares Outstanding | -6.80% | -5.26% | -4.13% | -4.82% | -3.85% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.34% | -56.57% | 0.05% | 0.29% | -0.86% |